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Abstract: Background: We investigated pregnant women, community leaders, healthcare workers
(HCWs) and programme managers’ perceptions of maternal vaccination in Kampala, Uganda. Meth-
ods: We conducted focus group discussions, key informant interviews and in-depth discussions
with HCWs (3), community leaders (3), pregnant women (8) and programme managers (10) between
November 2019 and October 2020. Data were analysed thematically. Results: Pregnant women,
community leaders and some HCWs had limited maternal immunisation knowledge. There was
confusion over what constitutes a vaccine. Pregnant women may not receive vaccines because of
mistrust of government; use of expired vaccines; reliance on traditional medicine; religious beliefs;
fear of side effects; HCWs attitudes; and logistical issues. The key facilitators of maternal vaccination
were a desire to prevent diseases, positive influences from HCWs and information about vaccine
side effects. Community leaders and some pregnant women highlighted that pregnant women
do not make decisions about maternal vaccination independently and are influenced by different
individuals, including other pregnant women, older people, partners, relatives (parents), community
leaders, HCWs and the government. Conclusions: Our results indicate that public health messaging
should target all community members, including partners and parents of pregnant women as well as
HCWs, to improve knowledge of and confidence in maternal vaccines.
Keywords: vaccine hesitancy; maternal vaccines; vaccine safety; vaccine confidence
1. Introduction
Infectious diseases cause morbidity and mortality in the antenatal, postpartum, neona-
tal and early infant periods [1]. On a global scale, maternal immunisation programmes have
made great progress in preventing and reducing infection rates in mother and infant [2].
To maintain these achievements, it is important to ensure that existing and new maternal
vaccination programmes are tailored to the contexts in which they are being delivered.
This tailoring includes considering beneficiaries’ perceptions and experiences of maternal
vaccines and related programme delivery to identify possible concerns that could under-
mine confidence in vaccination. The importance of contextualised and tailored delivery of
vaccination programmes is recognised by the World Health Organization (WHO), noting
that vaccine hesitancy is one of the current threats to global health [3].
Maternal vaccination has the potential to protect pregnant women and their infants
by enabling the transfer of antibodies from mother to child via the placenta and in breast-
milk [4]. Currently, the WHO recommends maternal vaccination against tetanus, pertussis,
and influenza, as well as other vaccines such as pneumococcus [5].
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Tetanus vaccination is the most widely implemented maternal vaccine programme in
low- and middle-income countries and the only maternal vaccine officially approved in
Uganda [6]. In Uganda, all 15–49-year-old women are offered a schedule of five separate
tetanus vaccine doses, starting at age 15 and during their pregnancy (two per pregnancy)
in addition to childhood vaccines [7,8]. Recent data from Uganda show that, in 2019,
only 65% of pregnant women received two doses of the tetanus vaccine during their
pregnancy [9], indicating incomplete coverage and compromised tetanus protection for
women and their infants. The 2016 Uganda Demographic and Health Survey also shows a
decreased proportion of births protected against neonatal tetanus from 84% in 2011 to 81%
in 2016 [10].
Currently, there is limited evidence on factors that may influence pregnant women’s
acceptance and refusal of maternal vaccination in Uganda that could be used to inform
public health programmes [11]. However, studies in other countries report various factors
that affect vaccination uptake; for example, in Somalia, concerns about vaccine safety and
limited knowledge were mentioned to have affected vaccine uptake among the women [12].
The objective of this study was to develop a better understanding of perceptions around
maternal vaccination in Uganda, focusing on the factors that could influence pregnant
women’s decisions to accept or refuse vaccination during pregnancy.
2. Materials and Methods
We undertook key informant interviews (KIIs), focus group discussions (FGDs) and
in-depth interviews (IDIs) between November 2019 and October 2020 to explore HCWs,
programme managers, community leaders and pregnant women’s views of the factors
influencing maternal vaccination uptake in Uganda.
2.1. Study Site
This study was conducted in Kawempe, the largest division in Kampala, the capital
city of Uganda, with an estimated population of 338,665 [13]. FGDs and KIIs were con-
ducted in and around the Kawempe division. IDIs and some KIIs were held at the office of
the interviewee or in residential areas around the local referral hospital.
2.2. Study Recruitment
Pregnant women, community leaders and HCWs were invited by the research team
at Kawempe to take part in the study. Programme managers were invited to take part
through emails and phone calls by the social scientists involved in the study.
HCWs were purposively recruited from the antenatal department, labour suite, im-
munisation and postnatal departments of the hospital. Programme managers included
health workers or staff with vaccination managerial roles within the Ministry of Health and
Kampala government health facilities. Community leaders from the villages surrounding
the hospital were identified and selected to include a mix of religious leaders, community
leaders, village health teams, traditional birth attendants and women leaders. Pregnant
women at different stages of pregnancy were recruited from the antenatal department at
the hospital. Women who took part in FGDs were divided into three groups: younger
mothers (17–24 years), more mature women (>25 years) and women with more than
three pregnancies.
2.3. Topic Guides and Data Collection
Semi-structured topic guides were designed to obtain the participants’ sociodemo-
graphic information, as well as information on the participants’ vaccine awareness and
vaccination experiences and their views on the factors that influence maternal vaccination,
including influencers that shape pregnant women’s decision to be vaccinated.
After providing written informed consent, participants took part in FGDs, KIIs or IDIs,
conducted by experienced qualitative interviewers, lasting between 60 and 120 min. For
the non-literate participants, friends and partners served as witnesses of the consenting
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process. All interviews took place in a private setting that was safe for both participants
and researchers. Interviews were conducted in English and in Luganda for participants
who did not understand English. Pregnant women were selected on the basis of age and
parity. The HCWs, community leaders and programme managers were selected based on
their roles in the community and maternal vaccination.
2.4. Data Management and Analysis
All FGDs, IDIs and KIIs were audio-recorded, transcribed verbatim into Microsoft
Word, and if conducted in Luganda, translated into English. The transcripts were cross-
checked against the audio recordings by the research team to ensure accuracy.
A coding framework was developed by P.N., F.Z., L.A., P.A. and E.K. based on the
questions included in the topic guide, the study objectives and pilot coding of two inter-
views. Anonymised transcripts were coded manually by PN using the coding framework
in Excel. Data were analysed thematically, drawing on themes based on the research objec-
tives related to vaccine perceptions used in the interview guide as well as those emerging
from the data. The analysis was an iterative process of discussion and revision among
co-authors.
3. Results
A total of 135 participants took part in this study, including 28 HCWs divided into
three FGDs, 10 programme managers for KIIs, 25 community leaders divided into three
FGDs and 72 pregnant women, 12 of whom took part in IDIs and 60 took part in 8 FGDs.
The following three key themes were identified during analysis: (1) awareness of
maternal vaccines, (2) facilitators and deterrents of maternal vaccination, and (3) the role of
influencers in decision-making. They are described in further detail below.
3.1. Awareness of Maternal Vaccines
While some HCWs, programme managers and pregnant women demonstrated an
awareness of available maternal vaccines (tetanus toxoid/tetanus diphtheria), a few com-
munity leaders and most pregnant women referred to different types of treatments given
during antenatal care (ANC), such as malaria prophylaxis/treatment (e.g., Fansidar) and
antiretroviral treatment for HIV as vaccines.
When asked about maternal vaccination, HCWs and programme managers also re-
ferred to Anti-D (a prescription medication used to prevent rhesus immunisation, also
known as rhesus incompatibility) and magnesium sulphate, as well as vaccines not cur-
rently given during pregnancy such as those against hepatitis B and rubella.
“We have another vaccine we give to women and it is called Anti-D. It is mostly given
to women who are rhesus negative for example when they have ‘A’ negative. Therefore
such a woman is given an Anti-D vaccine to prevent the baby from dying.” (FGD1,
Healthcare workers)
3.2. Perceived Facilitators and Barriers or Deterrents to Maternal Vaccination
3.2.1. Barriers to Maternal Vaccination
Participants mentioned various factors likely to hinder pregnant women from receiv-
ing maternal vaccines.
3.2.2. Rumours and Conspiracy Theories
Some pregnant women discussed women’s mistrust in relation to the use of expired
vaccines which “affect the baby’s brain” (pregnant women’s FGD5), which affected percep-
tions around the safety of vaccines.
Conspiracy theories were also perceived by HCWs and programme managers as an
important factor that could hinder maternal vaccine uptake. They described women who
believed that there was a hidden agenda related to population control in the provision of
maternal vaccines:
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“There is a myth where people think that maybe government put some harmful things
in the vaccines. That is why they even refuse their children from being immunised. In
the village, they think that if you take those vaccines, you can die.” (FGD2, Health-
care workers)
“They say that the ‘Bazungu’ [whites] want to kill them. They say that the Bazungu
have their tricks and that is the way they want to reduce the [number of] Africans [by
causing infertility].” (FGD2, Healthcare workers)
In addition to these rumours, apprehension around vaccine safety was also expressed.
All participants believed that a strong deterrent to maternal vaccination is some women’s
belief that vaccines may cause side effects:
“Currently, if a pregnant woman gives birth to a child, they get jaundice. Some people
think that the vaccines they use to vaccinate pregnant women are the ones that cause
such illnesses like jaundice. That is why most people don’t want to go to the hospital
to get that western medicine [vaccines] because of the fear of side effects.” (FGD1,
Community leaders)
“They say that some of these vaccines make their baby boys infertile. So they tell us
that we should not step at their doorstep [to mobilise them for vaccination].” (FGD2,
Healthcare workers)
“Some people think that vaccines make them have stillbirths.” (FGD2, Community leaders)
Pregnant women were perceived to trust in local remedies, which they might use
instead of Western medicines or vaccination.
“In most cases people in the communities trust their local herbs and they are the ones
they mostly use so that is why some people take them and even fail to go to the hospital to
attend antenatal [care].” (IDI2, Pregnant woman)
HCWs and pregnant women also believed that fear of pain or injections could affect
uptake of maternal vaccines by pregnant women.
“Most women just fear the pain of the injection. Even if you tell them the benefits of the
vaccines, they boldly tell you that the injection is so painful.” (FGD1, Healthcare workers)
The Role of Religion
Religious beliefs were perceived by HCWs, community leaders, pregnant women
and programme managers as a factor that could deter maternal vaccination uptake. Some
religious groups were said not to accept certain medications, such as Jehovah’s witnesses,
some Pentecostal Christians and Tabliqs (a Muslim group). The participants explained
that members of these groups believed that certain medications are associated with satanic
practices and receiving them would be disrespectful to their God.
“There is also my neighbour who usually tells me that I shouldn’t get vaccinated because
health workers don’t work better than God. My neighbour is a ‘born-again’ [Pente-
costal] and she usually says that God is better than all those health workers.” (FGD2,
Pregnant women)
In addition to such beliefs and concerns, there were also practical issues that hin-
dered uptake.
Time and Logistics
Distance and lack of transport to the vaccination site affected pregnant women’s ability
to access vaccination.
“Sometimes the long distances they have to travel to go to the hospital to get vaccinated
hinder them. One may be staying here [suburbs] yet the hospital where they vaccinate
from is as far as Kampala [City Centre] and if the woman doesn’t have transport, she may
lack the energy to walk up to the hospital.” (FGD1, Community leaders)
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Some pregnant women also reported time and logistic barriers related to their work as
something that could deter them from getting vaccinated during pregnancy. For example,
one woman was unable to get vaccinated because she could not leave work:
“I am a teacher and it is very hard to be permitted to get leave at the school where I am
working. I even get difficulties taking my children for immunisation. [ . . . ] If you ask for
a leave day at school, our bosses feel like it is burden for them. If you take like three days
off at school, they might even reduce on your salary. I usually start attending antenatal
at five months so that I visit the hospital like three times instead of starting early and
having to visit the hospital several times.” (FGD6, Pregnant women)
Other pregnant women reported long queues at the facility as something that could
deter maternal vaccination. They reported that there are usually many pregnant women
waiting at the facilities to receive vaccination services.
“One may say ‘the line is too long for me to wait yet I have things to do’. So such a
woman ends up not getting vaccinated. [She] may come back the second time at the
hospital and the moment she realises that the line is too long, she just goes back without
getting vaccinated.” (IDI3, Pregnant woman)
Being late for antenatal visits was also reported as a deterrent to maternal vaccination
by some pregnant women. Since vaccination for women is integrated into antenatal
services, some women who report late for antenatal care end up missing these services.
HCWs’ attitudes and the way they interact with pregnant women were also reported
by community leaders as one factor that could hinder maternal vaccination.
“Health workers should not be tough before those women. That is one of the things that
makes women refuse to get vaccinated. They fear going to the hospital because the health
workers abuse them and sometimes shout at them.” (FGD3, Community leaders)
3.3. Facilitators for Maternal Vaccine Uptake
When participants were asked about what they thought could facilitate maternal vacci-
nation uptake and acceptance, they mentioned several factors, including positive influence
from HCWs, perceptions about the tolerability of the vaccine, access to vaccination, as well
as the positive influences from partners or relatives.
HCWs and programme managers thought that pregnant women may be more likely
to accept vaccination if they are actively motivated by HCWs. They explained that since
pregnant women are usually asked about their ANC attendance around the time of de-
livery, pregnant women think that a failure to attend such sessions may mean that they
will get less attention from HCWs who believe they may have missed appointments,
including vaccination.
“The women go for ANC with their different reasons. [ . . . ] they know that the midwives
will harass them if they don’t have a TT [Tetanus vaccine] or antenatal card.” (KII3,
Programme manager)
Pregnant women perceived that receiving information on vaccine side effects could
facilitate maternal vaccine uptake, with women more willing to accept vaccines that are
“tolerable” or with fewer side effects.
“Apart from the pain, so far Td is tolerable. Uptake would be bad if the vaccine adminis-
tered in pregnancy is hard to tolerate as a pregnant woman. Apart from the arm being
paralysed for the next two days, it is tolerable. At least that is the vaccine I have known
which is being administered among the pregnant women. The vaccine not being tolerated
would affect the uptake. The current vaccine is tolerable.” (KII9, Pregnant woman and
programme manager)
Being knowledgeable about the benefits of maternal vaccines also influenced the
decision to vaccinate, with some pregnant women accepting vaccination during pregnancy
to protect themselves and their babies from getting infections.
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3.4. Role of the Community in Influencing Vaccination Decisions
Community leaders and some pregnant women explained that pregnant women do
not make decisions about maternal vaccination by themselves and are influenced by others,
including other pregnant women, older people in the community, their partners, relatives
(particularly their parents), community leaders, HCWs and the government.
“Some women tell their fellow women that the injection for the tetanus vaccine is very
painful and those who have never had that vaccine get scared and don’t get vaccinated.”
(FGD1, Community leaders)
Older people were perceived by community leaders and pregnant women as possible
influencers in pregnant women’s decision to vaccinate and sometimes make decisions for
them. Community leaders explained that as vaccinations were not available for pregnant
women in the past (tetanus vaccination was recommended in pregnancy by the WHO in
1998) and children were seen as growing up to be healthy, older generations believed that
vaccines were not necessary for pregnant women.
“[ . . . ] grandparents or people who are older than us [ . . . ] say that they gave birth to
our mothers when they had not been vaccinated. So, the women get influenced by those
older people and start saying ‘if my grandparent gave birth without getting vaccinated, I
will also refuse to get vaccinated.’” (FGD3, Pregnant women)
“Some older women discourage us from receiving those vaccines since some are expired;
they usually tell us that those vaccines can make a woman give birth to a child with a
disability.” (FGD2, Pregnant women)
Community leaders said that a woman’s partner could influence the decision to
vaccinate. They explained that in some homes, men’s decisions are considered more
important due to the patriarchal structure of most families, with women not allowed to
make decisions before consulting their husbands. If men refuse vaccination for their wives,
pregnant women will follow their husband’s decision.
Community leaders were also believed to play an important role in influencing women
to make decisions about maternal vaccination. Community leaders such as Village Health
Teams (the lowest tier of the government health service), local council and religious leaders
were perceived by community leaders as a group of people that influence women’s decision
to vaccinate because pregnant women trust what they say. Therefore, if community leaders
do not accept any kind of medication, it was perceived that the people they lead are most
likely to follow what they do.
Community leaders said that the role of influencers on decision-making can be limited
by governments mandating certain interventions, such as maternal vaccination. They
explained that some women may accept vaccination, because they believe it is a govern-
ment requirement:
“Whether you accept or not, the government can force you to get vaccinated. If they make
it a must for everyone to get vaccinated as they recently did to the children who were
in school, you must get vaccinated. We even saw some parents being taken to police for
refusing to get their children vaccinated. If something is beneficial to the mother and the
baby, the government can make a decision for us.” (FGD3, Community leaders)
However, some pregnant women believed that they were the ones responsible for
making their own decisions about vaccination. The consensus among women was that the
decision to receive maternal vaccines is made by the pregnant woman, regardless of other
influencers such as relatives, older women and community members.
4. Discussion
We have described pregnant women, community leaders, HCWs and programme
managers’ perceptions of the barriers to and enablers of maternal vaccination and the role
of community and family in decision-making in an urban Ugandan setting.
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Despite tetanus vaccines being the only approved vaccines in Uganda, participants
described other ANC treatments given to women as “vaccines”, which could imply an
important knowledge gap. This could be due to the fact that tetanus toxoid vaccination
during pregnancy is integrated into antenatal care [10], leading to participants’ confusion
and difficulty in differentiating between interventions or, as we found, due to the perception
that all medication that protects against infection is a “vaccination”. A study in Eastern
Uganda also identified issues with women describing antimalarial medication as a vaccine,
which highlights the need for future public information campaigns to focus on the meaning
of vaccination [11].
Globally, concerns regarding maternal vaccine safety is one of the major barriers to
vaccination during pregnancy [14] and this is reflected in our results, where safety concerns
might affect the decision to vaccinate. This is also true of other African countries, such as
Kenya and South Africa, where one of the main barriers to maternal vaccination is vaccine
safety concerns and fear of side effects [14–16].
Trust in the intention of global health bodies and governments in recommending
vaccination is critical for uptake of maternal, as well as other vaccine services [17,18].
In recent years the use of social media has encouraged the sharing of mis-information
about vaccines [19], but, as shown in our study, rumours fuelled by fears over unwanted
external influence have long undermined trust in vaccination programmes and the health
workers providing the vaccinations [18,20]. The increase in antivaccination movements
in Uganda and internationally can only be tackled with sustained dialogue with the
communities receiving immunisation to improve vaccine confidence. While mandating
vaccines or imposing penalties for non-vaccination has been proposed as a strategy to
increase vaccination uptake, such strategies can also entail important ethical challenges,
especially if they are not implemented together with tailored information materials and
complemented by community engagement strategies to improve trust in vaccination [19].
The effect of distance on the utilisation of health services in settings increases when
it is combined with lack of transportation [21]. Our findings concur with other research
reporting distance to service delivery points as one of the major factors leading to low
vaccination coverage in Uganda [22]. Time taken to attend antenatal care is also highlighted
as a potential barrier to vaccine uptake, indicating that this is a key area of capacity
strengthening required in vaccination programmes in pregnancy [23].
HCW attitudes are reported to hinder pregnant women from receiving antenatal care
in Kenya and South Africa, similar to our findings, thus affecting maternal vaccination
uptake [24,25]. It is important to consider the training implications of positive attitudes of
HCW towards women and their messaging on vaccination to ensure that high antenatal
vaccination coverage is maintained.
The influence of partners on maternal vaccinations uptake and acceptance during
pregnancy was highlighted in our study. Other research in Uganda has shown the impor-
tant role of male partners in maternal decision-making about childhood vaccination [26],
and male partners were found to act as strong influencers on pregnant women’s overall
health and their access to care in South Africa [27]. A literature review that was conducted
to understand the factors that contributed to vaccine uptake among pregnant women
also presented five articles where pregnant women’s husbands significantly affected their
likelihood to be vaccinated [28].
Our study highlighted the importance of religious beliefs in the decision to vaccinate.
Uganda has different religious groups, which do not encourage their followers to engage
in vaccination services, who believe that their God cures every kind of illness and that
vaccinations are therefore not necessary [22]. A study of infant vaccination hesitancy
in Uganda also identified religious beliefs as one of the barriers to effective uptake and
provision of immunisation services [22] and similar results were found in Zambia [29].
Taken together, these findings indicate the importance of considering the wider community
in vaccine decision-making for pregnant women.
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Regardless of the findings from our study, which showed different factors that hinder
women from getting vaccinated, there are no laws imposed on whoever rejects the vaccines
in Uganda, yet one study conducted in Europe reported some legal enforcements that
encourage people to take up vaccines [20].
Limitations
There are several limitations to our study. We did not include interviews with the
partners of pregnant women, which could have provided important findings, as male
partners are important influencers in health and vaccination decisions in households in
Uganda. Furthermore, the study was only conducted in an urban setting and may not be
applicable to other settings such as rural areas. Our findings relate to a group of women in
Kampala, and, although many of our findings are similar to other Ugandan studies, they
may not be similar outside the country.
5. Conclusions
Our study findings show that knowledge of maternal vaccines and perceptions about
their use are limited among some pregnant women and others who may influence vaccine
uptake, suggesting the need for increased communication and engagement strategies
around maternal vaccination. We suggest that public health messaging target whole
communities and advocate for the co-creation of materials to make sure that the message is
relevant to all those making decisions about vaccination during pregnancy. The findings
from this study can inform policy makers, policy analysts and vaccination programme
managers to support the design of appropriate maternal vaccination programmes and
public health campaigns, taking into consideration the role of the different influencers that
play a key role in decision-making.
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